Compare Apartment Investment and Management Co (AIV) vs Boston Scientific Corporation (BSX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Apartment Investment and Management Co vs Boston Scientific Corporation — how do they compare? Apartment Investment and Management Co trades at $2.65 (market cap $379.07M), while Boston Scientific Corporation trades at $53.5 (market cap $74.52B). The key difference: Boston Scientific Corporation is far larger — about 196.6× Apartment Investment and Management Co's market cap, and Boston Scientific Corporation is trading nearer its 52-week high, Apartment Investment and Management Co nearer its low. Which is the better fit depends on your goals.
| AIV | BSX | |
|---|---|---|
Market Cap | $379.07M | $74.52B |
Sector | Real Estate | Health |
52-Week High | $7.93 | $108.14 |
52-Week Low | $2.59 | $42.63 |
Enterprise Value | $741.22M | $86.60B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AIV trades at $2.61, up 0.77% today, with a bearish technical signal from moving averages despite a neutral RSI. The company reported a net income margin of 400.05% for 2025, driven by a $554.01M profit, though revenue declined to $138.49M. Recent news includes Dimensional Fund Advisors reducing its stake by 49.2% in Q1 2026 (Defense World, 2026-08-13).
Outlook is mixed: strong profitability and a low P/B of 0.77 suggest undervaluation, but inconsistent earnings history and bearish technicals pose risks. Analyst consensus is cautious with 33.3% buy ratings, highlighting volatility in real estate operations as a key concern for investors.
Boston Scientific (BSX) trades at $51.69, up 0.98% today, with a bullish technical outlook supported by moving averages despite overbought RSI readings. The company shows strong fundamentals with Q2 2026 EPS of $0.86 beating estimates and revenue growth to $20.07B in 2025, alongside improving net income margins. Analyst sentiment is overwhelmingly positive with 86% buy ratings and a $67.21 consensus price target, though recent news highlights guidance cuts and competitive pressures in key segments like WATCHMAN.
The stock presents a compelling long-term opportunity given robust earnings growth and institutional confidence, but faces near-term risks from execution challenges and market volatility. Upside potential exists if the company stabilizes guidance and leverages new product catalysts, making it attractive for investors with a tolerance for sector-specific headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Apartment Investment and Management Co
Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment
Read more on AIV →About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →
